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Abstract 
The purpose of this quality improvement project was to increase performance and documentation 
of provider comprehensive foot exams (CFEs) by 50% among patients with Type 2 diabetes 
(T2DM) in a small clinic in the southwestern United States. The project leader assessed 
clinic systems including the electronic health record (EHR) to identify means to 
increase CFE completion and documentation rate for patients with T2DM being seen for a 
chronic disease management (CDM) appointment. A process was created to incorporate 
a hardcopy CFE documentation form into the EHR and create a pop-up care reminder 
notification system. Staff and the provider were educated on the new process, supplies were 
obtained, and the project leader implemented this project in the spring of 2020. The project 
leader monitored outcomes through a formative and summative evaluation plan and addressed 
barriers as they were identified. The COVID-19 pandemic impacted clinic practices in March 
2020 and led to modification of project outcomes as the platform for  appointments changed 
from in person to telehealth. The project outcome was achieved as 52% of patients with T2DM 
who were seen during a CDM appointments received a CFE that was documented completely. 
The average increase in appointment time was 10 min. Including CFEs in CDM appointments 
can support the identification of foot ulcers at an early stage and prevent or delay lower extremity 
amputations. EHR systems should be evaluated for the capacity to support electronic tracking and 
documentation of these assessments 
Keywords: Type 2 diabetes mellitus, comprehensive foot exam, electronic health record 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  8 
Implementation of Comprehensive Foot Exams in Primary Care:  
A Quality Improvement Project 
In 2015, 30.3 million Americans (9.4%) had Type 2 diabetes mellitus (T2DM)  
(American Diabetes Association [ADA], 2018). Among those 30.3 million Americans, 23.1 
million or 76.2% had an actual diagnosis, while 7.2 million or 23.8% remained undiagnosed 
(ADA, 2018). As recently as 2017, approximately 2,990,000 Texans have been diagnosed with 
T2DM; this is 14.6% of the adult population in Texas (ADA, 2017a). It is also estimated that 
about 663,000 of these Texans have diabetes but are not aware of it, placing them at much higher 
risk for complications from this disease (ADA, 2017a).  
According to the American Diabetes Association (ADA, 2017b), in 2017, T2DM cost the 
U.S. $237 billion in direct medical care costs making healthcare costs for Americans with T2DM 
2.3 times greater than healthcare costs for Americans without T2DM. This amount constitutes a 
26% increase in cost to care for persons with T2DM over the previous 5 years (ADA, 2017). 
Similarly, in 2017, healthcare costs for Texans with T2DM were 2.3 times higher than for 
Texans who did not have T2DM. (ADA, 2017a).  
Statement of the problem 
Currently, foot ulcers or wounds are one of the most common and preventable 
complications of diabetes mellitus (DM). Approximately 34% of patients with T2DM are at risk 
for developing a foot ulcer, more than 50% of those ulcers become infected, and around 20% of 
diabetic foot infections result in some form of a lower extremity amputation (LEA) (Armstrong 
et al., 2017). Both foot ulcers and amputations are consequences of T2DM and diabetic 
neuropathy; they are also significant causes of morbidity and mortality (ADA, 2019).  
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Foot ulcers can be prevented or detected at their earliest stages through comprehensive 
foot examinations (CFEs) as recommended by the Standards of Care in Diabetes-2019 for 
patients with T2DM (ADA, 2019). The American Diabetes Association (2019) recommends that 
providers perform a CFE with a 10-g monofilament yearly, and conduct foot inspections at every 
office visit for all patients with evidence of sensory loss or prior ulceration or amputation. 
Comprehensive foot exams and foot inspections are vital to early recognition and 
treatment of patients who are at risk for foot ulcers and amputation. According to the Centers for 
Disease Control and Prevention (CDC, 2017), only 62.9% of patients with T2DM living in Texas 
reported receiving a foot exam by a health professional while nationally 71.6% reported they had 
received the exam. This cost-effective exam requires little equipment, one monofilament per 
patient, can be time-efficient at approximately 3 min to complete and document the exam, yet 
can identify a foot ulcer or wound in its earliest stages and prevent or delay a LEA 
(Ming et al., 2019).  
Background and Significance 
Type 2 Diabetes Mellitus is a chronic, progressive health condition that affects the body's 
ability to use insulin to regulate blood sugar and use it as energy (CDC, 2019). Because T2DM is 
a progressive condition, individuals with this diagnosis are at risk for other long-term 
complications, including retinopathy, nephropathy, and neuropathy (ADA, 2019). Complications 
related to T2DM are due to damage of small (micro) and large (macro) blood vessels in the body. 
These complications are classified into microvascular and macrovascular complications (World 
Health Organization [WHO], 2020).  
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Macrovascular Complications 
Macrovascular complications of T2DM include coronary artery disease (CAD), 
peripheral vascular disease (PVD), and peripheral artery disease (PAD) (WHO, 2020). These 
macrovascular complications include cardiovascular diseases that affect not only the vessels in 
major organs and extremities but also those of the brain and heart. Hyperglycemia, or high blood 
glucose levels which can accompany T2DM, cause damage to blood vessels in the body by 
narrowing or occluding the vessels. These occlusions are called atherosclerosis (WHO, 2020). 
Atherosclerosis leads to decreased blood flow to major organs such as the brain or heart, and to 
the body's extremities, which may result in myocardial infarction, cerebrovascular accident, or 
even possible loss of a limb (WHO, 2020). 
Microvascular Complications 
 Microvascular complications related to hyperglycemia result from damage to capillary 
endothelial cells in the retina, neurons, mesangial cells in the renal glomerulus, and Schawn cells 
in peripheral nerves (Khalil, 2017). Long term exposure to hyperglycemia leads to oxidative 
stress from superoxide overproduction, in turn causing endothelial damage (Khalil, 2017). 
Microvascular complications such as retinopathy, which may result in blindness, nephropathy, 
which may result in kidney failure, and peripheral neuropathy, which may result in diabetic foot 
ulcers and subsequent LEA, are caused by direct damage to the small vessels in the eyes, 
kidneys, and nerves retrospectively (WHO, 2020).  
Onset and progression of diabetic retinopathy and nephropathy can be decreased through 
annual eye exams and urine and blood tests (ADA, 2019; WHO, 2020).  However, because 
peripheral neuropathy and diabetic foot disease result from both vessel and nerve damage, it is an 
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even more common problem than the other microvascular complications related to T2DM 
(WHO, 2020).  
Diabetic Peripheral Neuropathy 
Diabetic peripheral neuropathy (DPN) is a microvascular complication of DM and is the 
leading risk factor for diabetic foot ulcers. It occurs in 13-68% of persons with T2DM (Lung et 
al., 2020). This microvascular complication is caused by a shift in the balance between nerve 
fiber damage and nerve fiber repair, where damage supersedes repair (Feldman, 2020). The 
nerve damage occurs in a fiber-selective pattern, most commonly affects autonomic and distal 
sensory fibers, and may lead to the progressive loss of sensation, which is characteristic of 
diabetic neuropathy (Feldman, 2020).  
There is an array of factors that cause this shift in balance, such as chronic 
hyperglycemia, protein kinase activation (causing vasoconstriction), and oxidative stress. 
Impaired peripheral nerve repair is common with T2DM, and it is hypothesized that this could be 
due to the loss of neurotrophic peptides that typically mediate nerve repair and regeneration 
(Feldman, 2020). These peptides include insulin-like growth factors making glycemic control an 
imperative factor in preventing and slowing down the compromise of nerve repair and viability 
(Feldman, 2020).   
Diabetic peripheral neuropathy is a diagnosis of exclusion, making it difficult to diagnose 
and treat at an early stage (ADA, 2019). There are many treatment options for DPN; however, up 
to 50% of these cases are asymptomatic, and if unrecognized, they can lead to injury and 
disability in a person, including diabetic foot ulcers, infections, and LEAs (ADA, 2019; Lung et 
al., 2020). Additionally, DPN is the leading cause of disability in patients with T2DM due to 
ulcers, amputations, fall-related injuries, and gait disturbances (Juster-Switlyk & Smith, 2016).  
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Distal symmetric polyneuropathy (DSPN)  is the most common type of diabetic 
neuropathy and accounts for 75% of DPNs (Pop-Busui et al., 2017). This type of neuropathy is 
considered idiopathic in about one-third of its cases, and DM is the second most common cause 
(Callaghan et al., 2020). Individuals with DSPN often present with tingling, numbness, pain, 
and/or weakness that starts in the toes and progresses proximally in a "stocking-glove" 
distribution (Callaghan et al., 2020). Distal symmetric polyneuropathy neuropathy is the leading 
cause of foot ulcers and is commonly present in at least 10-15% of patients with a new diagnosis 
of T2DM. This type of neuropathy presents in 50% of persons with T2DM within 10 years after 
the initial diabetes diagnosis (Pop-Busui et al., 2017).  
Foot Ulcers and Amputations 
Approximately 25% of persons diagnosed with T2DM are likely to develop a foot ulcer 
during their lifetime (Hicks & Selvin, 2019).  Diabetic peripheral neuropathy accounts for 90% 
of hospital admissions related to diabetic foot ulcers, and 83% of all major amputations in the 
U.S. are caused by a complication from DM (Hicks & Selvin, 2019). From 2011-2014, the CDC 
(2016a) documented a total of 102,835 LEAs in the United States, and 86,800 (84.4%) were 
attributable to DM. In 2014, the CDC (2016b), reported a total of 11,488 LEAs in the state of 
Texas; 10,040 or 87.4% of those amputations were attributable to DM. The Texas Department of 
Health Services reported that Bexar County had the highest number of hospital admissions 
related to LEAs among all Texas counties (Sunil et al., 2019). According to the San Antonio 
Metropolitan Health District (2019), the rate of LEA related to DM has consistently been higher 
in Bexar County than the overall rate in Texas, with Bexar county reporting a rate of 9.7 per 
10,000 people and Texas reporting a rate of 6.5 per 10,000.  
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 Because DPN is a progressive and irreversible complication associated with DM, 
patients who have a history of foot ulcers and poor diabetes management are at high risk for 
developing ulcers that lead to amputations (Hicks & Selvin, 2019). Raghav et al. (2018) state that 
the annual expenditure for diabetic foot care or disease is $8,659 per patient; the medical costs 
for a lower limb amputation (below the ankle) equates to approximately $43,800, while the cost 
for amputations above the ankle increases to, on average, $66,215.  It should be noted that a 
significant part of the expenditure was not from the surgeries but from rehabilitation and nursing 
care required after the acute care stay (Raghav et al., 2018).  Comprehensive foot exams and 
patient education about foot care are one evidence-based recommendation that can be conducted 
inexpensively in the primary care setting and may identify foot ulcers and other diabetic foot 
complications before amputation becomes the only treatment option (ADA, 2019; Lung, 2020). 
             Assessment 
 The project leader completed an assessment of the primary care clinic located in a large 
metropolitan city in the southwestern United States.  This assessment took place over 3 months 
and largely followed the Dartmouth Institute Microsystem Academy (2005) clinical 
microsystems format.   
The clinic consists of a front desk with a waiting area and a clinical space that includes 
patient exam rooms and a section where laboratory specimens are collected and processed. The 
patients check-in and check-out at the front desk, which is staffed by one medical assistant 
(MA). During a typical visit (without the requirement of social distancing), the waiting room can 
accommodate seven to eight patients at a time. During the stay home, work safe period requiring 
social distancing by the local government, the waiting room did not accommodate any patients. 
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Patients with appointments were expected to call via telephone to check-in and wait in their 
vehicles until they were called in by office staff.  
When patients were brought to the clinical area, there was a designated space where vital 
signs and labs were obtained. There were three patient exam rooms where the provider examined 
patients and located at the back of the office was the provider's office, a break room, two 
restrooms (one for staff and one for patients), and a designated area for lab processing, supplies, 
and medication storage.  
Purpose of Practice 
The primary clinic did not have a formally stated mission; however, this practice focused 
on acute care and chronic disease management of families. The provider at this clinic cares for 
patients across their lifespan by integrating clinical and behavioral sciences.  
Professionals  
The primary care clinic is composed of one family practice physician, three MAs, and 
one registered nurse (RN) who only focuses on chronic care management (CCM). Because a 
large number of patients are Spanish speaking, all staff is bilingual, speaking English and 
Spanish. The role of the RN was to complete CCM follow-up calls and visits for patients insured 
by Medicare. The RN contacted patients to ensure that they were taking medications as 
prescribed, answered questions about medications or vital signs, set up follow-up appointments 
with the provider, assessed home safety, and ensured and that they had the adequate resources to 
manage their chronic illnesses. The goal was to prevent patients from needing hospitalization and 
preclude unnecessary ER visits. As of June 2020, the RN position was vacant.  
Each of the MAs took turns working at the front desk, completed office duties, obtained 
lab specimens, assisted the provider with procedures and basic examinations, and administered 
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medications such as intramuscular injections. In addition to their daily responsibilities, each MA 
completed prior authorizations, initiated referrals to specialists, set up patient rooms, or sent out 
laboratory requisitions as needed or directed by the provider.  
Patients  
There are a total of 5,328 active patients in the practice, of which 69% are female, and 
31% are male. The provider conducts approximately 644 patient visits every month.  Fifty-five 
percent (2,950 patients) of the patients in this practice have been diagnosed with T2DM.  A vast 
majority of the patient population is Spanish-speaking, where 59.2% of patients identify 
themselves as Hispanic/ Latino.  Table 1 contains a breakdown of patient characteristics.  
Table 1 
Patient Population 
Race/Ethnicity n % 
American Indian or Alaska 
Native 1 0.02 
Asian 28 0.53 
Black or African American 145 2.72 
Hispanic/ Latino  3,154 59.2 
Non-Hispanic White 1,793 33.65 
Unspecified  207 3.88 
Note. N = 5,328 active patients 
Processes 
 The average patient visit can range from 30 min to 1 hr, depending on how busy the 
clinic is that day and the needs of the patient. There is only one provider onsite who sees patients 
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by appointment. The clinic also reserves time slots for same-day appointments. A chronic 
disease management appointment may last 30 to 45 min, and an appointment for a new patient 
with chronic diseases can take anywhere from 60 to 90 min depending on the labs required and 
the extent of the examination. When patients arrive, they sign in at the front desk, and they are 
given paper forms to update their information as needed and to write down the names of the 
medications they need to be refilled. Before the patient is taken to the exam room, the MA 
obtains their vital signs and asks about the reason for their visit and any new medications. Once 
patients have seen the provider and the required labs have been completed, they are accompanied 
to the front desk to check out where their copay is collected, and their next follow-up visit is 
scheduled.  
This medical office maintains patient records through an EHR system that is capable of 
organizing the patient schedule, billing for visits and procedures, sending electronic 
prescriptions, sending referrals to other providers, and tracking required tests such as 
mammograms, lipids, hemoglobin A1cs, and immunizations. The office no longer stores any 
hard-copy records; hard-copy documents such as the forms that patients fill out with their 
medication refill requests are scanned directly into the EHR and shredded after the appointment. 
The EHR has many features that the provider uses daily such as the ones described above. 
However, if the provider would like to add additional features, they would have to pay for these 
features, which can cost up to $1,000. The provider has been using this EHR system for the last 5 
years, and if there are any difficulties with setup or processes, they can contact the representative 
of the help desk directly.  
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Patterns 
At the time the microsystem assessment was conducted, there was no system in place that 
reminded the provider to perform CFEs; this played a significant role in these foot exams not 
being performed at the recommended frequency. Currently, the clinic's EHR has the capability to 
send pop-up reminders to the provider when a core measure or guideline is due for a patient. For 
example, there is a system in place to notify the provider when the patient is due for labs or 
exams like an HgA1c, lipid levels, a colonoscopy, or a mammogram. The system has the 
capability to track these exams in a spreadsheet where the provider can easily find completion 
dates and results. CFE's were the only assessment that did not have a notification system in place 
and that did not appear in the spreadsheet.   
Foot inspections were being performed according to ADA guidelines and as a part of the 
physical assessment. There was in fact, an area to document CFEs in the physical assessment 
section for each patient visit. However, there was no way to keep track of the completion of 
CFEs unless the user examined each individual chart or performed a search using current 
procedural terminology (CPT) codes.  
The project leader conducted a report using the EHR that listed the number of CFEs 
billed for and identified nine (0.3%). This was discussed with the provider, and the provider 
expressed concern with the results. The provider explained that CFEs were being performed, but 
the documentation must have not been performed. The EHR does provide a template on the 
physical assessment section for the foot exams, but it does not populate a report to keep track of 
their completion.  
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Need for Intervention 
During the assessment process, the project leader noted that CFEs were not being 
performed consistently or regularly for patients with T2DM. The project leader systematically 
reviewed the clinic's EHR and retrieved documentation for nine patients. The CFEs that were 
completed followed ADA guidelines in the way that they were performed but were not 
completed at the recommended frequency. Because the system currently in place has not proven 
efficient with documentation, tracking, or establishing frequency reminders for CFEs, the project 
leader consulted with the provider and determined that it would be best to use a hardcopy CFE 
template and set up a notification system in the EHR.  
Readiness for Change  
After completing the assessment, the project leader met with the provider and staff to 
discuss the findings. During this meeting, education on ADA Standards of Medical Care-2019 
was presented with an emphasis on the significance of CFEs. The provider and the office staff 
were open and accepting of the assessment and plan. Throughout the assessment period and 
during this meeting, the project leader evaluated the team's readiness for change.  
The first step in implementing change is to identify and evaluate readiness for change. 
One must assess the culture of an organization to recognize the barriers and facilitators (Tappen 
et al., 2017). The project leader previously completed a clinical rotation at the site and had built a 
rapport with the provider and staff, which served as a facilitator for the initiation of this project. 
The established rapport was beneficial as it allowed the staff and provider's openness to 
suggestions and to the possibility of changing the office flow. Another indicator of readiness was 
the interest that the staff had related to this project. The staff was inquisitive and interested in 
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learning about the benefits of CFEs and even contributed ideas on how this project could be 
sustained once the project leader completed the intervention.  
Other factors associated with readiness for change were taken into consideration. One 
factor taken into account was personnel. It was essential to ensure that there would be sufficient 
personnel; adding tasks to an already stressed and understaffed personnel has the potential to 
create a hostile environment and could negatively affect the implementation of any project. This 
clinic had proper staffing and the staff appeared to work well together. Another factor considered 
was finances and an effect on daily working patterns. It was of great importance to confirm that 
the site had the financial means to purchase supplies and to support any additions to the daily 
flow of patient appointments. These factors were discussed with the provider and with the 
employee in charge of billing to ensure that the implementation of this project would not be cost-
prohibitive nor negatively affect the daily workflow during the implementation phase. Neither 
issue was deemed to be problematic.  
The last factor considered was space. The project site was a relatively small office with 
accommodations for 10 to 11 patients at a time (including the waiting area) pre-pandemic. It was 
crucial to discuss the use of space for project implementation with both the provider and the 
staff. The aim was to complete this project without creating disruptions or disarray.  The 
provider and billing specialist agreed that the project could be initiated and sustained in the 
current office space. Overall, the provider and the office staff were open and accepting of the 
assessment and plan and demonstrated readiness for change.  
A barrier that concerned the project leader was time. Specifically, there was concern that 
conducting CFEs would increase the length of time a patient spent in the office, the time the 
provider needed to be with the patient and the time that MA staff spent preparing patients and 
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processing the CFE documents after patient visits. Patients being seen for a CDM appointment 
were already spending nearly an hour at the clinic for a regular visit, and the project leader was 
concerned that a more extended patient visit could result in patient dissatisfaction. Additionally, 
the project leader was worried that the exams might begin to dissipate if they added too much 
time to a CDM appointment. This concern was resolved in the planning stages by assisting the 
provider and staff as much as possible with procuring supplies and developing documents to 
prevent the prolongation of patient visits.  
Project Identification 
Purpose 
The purpose of this quality improvement (QI) project was to institute an evidence-based 
practice recommendation from the ADA Standards of Medical Care-2019 to conduct CFEs for 
patients with T2DM at a small primary care clinic in the southwestern United States.  
Objectives and Anticipated Outcomes  
1. Create and utilize electronic or paper CFE documentation form that would be 
accepted by the Center for Medicaid and Medicare Services by January 2020 with 
input from the provider.  
a. Anticipated outcomes: the provider will approve electronic or paper CFE 
documentation form. 
b.  The form will be utilized by the provider upon the initiation phase to 
document all CFEs. 
2. Design and implement necessary processes for staff and provider to incorporate CFEs 
for patients with T2DM during routine CDM appointments by January 2020 and 
adjust as needed. 
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a. Anticipated outcomes: The project leader will direct provider and staff on the 
incorporation of the CFE process into the daily workflow for appropriate 
patients. 
b.  Staff and provider will begin implementing the CFE process, and the provider 
will perform and document exams starting in February 2020.  
3. By April 2020, increase to 50% provider performance and documentation of CFEs 
based on 2019 ADA standards. 
a. Anticipated outcome: Performance of CFEs will reach at least 50% overall by 
April 2020, as evidenced by documentation of all portions of the exam 
(medical history, current history, foot exam, sensory foot exam, risk 
categorization). 
b. All CFEs performed will be documented completely based on form. 
4. Create and implement formative and summative evaluation processes to assess 
progress towards 50% completion and documentation of CFEs.  
a. Anticipated outcome: Weekly flow sheets will demonstrate progress towards a 
50% increase; in the event, this goal is not reached weekly second outcome is 
anticipated. 
b. Meeting with staff and provider to identify and address barriers to 50% 
completion and documentation rate with changes made to process as 
necessary.  
Summary and Strength of the Evidence 
Each year the ADA publishes the Standards of Medical Care in Diabetes. These 
standards of care are intended to provide tools and recommendations to clinical providers to 
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assist with the treatment and chronic management of DM. The ADA's professional practice 
committee performs extensive research and disseminates literature to construct these guidelines 
with the most updated standards and regulatory changes. Recommendations by the ADA are 
based on well-designed clinical trials or meta-analyses, and the level of evidence grades them. 
The levels of evidence range from A to E; a level A grade is given to well-conducted, 
randomized controlled trials while a level E grade is based on expert opinions or 
recommendations (ADA, 2019). See table 2 for the full description of each level of evidence 
used by the ADA. These grades are essential as each evidence-based guideline from the ADA 
carries the grade that correlates with the level of evidence supporting the recommendation. 
Specific recommendations from the ADA (2019), which form the basis of this evidence-based 
project are listed in table 3. 
Table 2  
ADA Evidence-Grading System  
Level of evidence Description 
A Well-conducted, randomized controlled trials that include evidence from a 
well-conducted multicenter trial or a meta-analysis with incorporated 
ratings. 
B Supportive evidence from well-conducted cohort studies, meta-analyses of 
cohort studies, or supportive evidence from well-conducted case-control 
studies. 
C Supportive evidence from poorly controlled or uncontrolled studies; 
evidence from observational studies with potential for bias; evidence from 
case series or case reports. 
E Expert consensus, opinions, recommendations, or clinical experience 
Note.  Adapted from "ADA Evidence-grading System for Standards of Medical Care in 
Diabetes," by American Diabetes Association, 2019, Diabetes Care,42, p. s2 
(http://dx.doi.org/https://doi.org/10.2337/dc19-Sint01). 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  23 
 Table 3 




B Perform a comprehensive foot evaluation at least annually to identify risk 
factors for ulcers and amputations (p. s133). 
B All patients should be assessed for diabetic peripheral neuropathy starting 
at diagnosis of type 2 diabetes…and at least annually thereafter (p. s131). 
C Patients with evidence of sensory loss or prior ulceration or amputation 
should have their feet inspected at every visit (p. s131). 
B 
Assessment for distal symmetric polyneuropathy should include a careful 
history and assessment of either temperature or pinprick sensation…and 
vibration… All patients should have annual 10-g monofilament testing to 
identify feet at risk for ulceration and amputation (p. s131). 
C 
Patients with symptoms of claudication or decreased or absent pedal pulses 
should be referred for ankle-brachial index and further vascular assessment 
as appropriate (p. s131). 
Note.  Adapted from "Microvascular Complications and Foot Care," by American Diabetes 
Association, 2019, Diabetes Care,42, p. s131-s133 
(http://dx.doi.org/https://doi.org/10.2337/dc19-Sint01).  
Standards of Care 
The ADA (2019), recommends as one of its evidence-based standards that all patients 
should be assessed for DPN through a CFE as soon as they are diagnosed with T2DM and that 
these examinations should be conducted at least yearly after that. Patients who, upon exam, 
present with sensory loss or with a history of ulceration or amputation should have their feet 
inspected at every visit. According to the ADA (2019) recommendations, the patient's provider 
should obtain a detailed history regarding any foot abnormalities, previous wounds or ulcers, 
amputations, or infections (ADA, 2019).   
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  24 
The provider should assess for DPN by testing for loss of sensation using a monofilament 
to assess small fiber function (ADA, 2019; Lung, 2020). Comprehensive foot examination 
should include inspection of the skin to look for calluses or ulcers, assessment and identification 
of foot deformities, a neurological assessment to assess small fiber function and protective 
sensation using a 10-g monofilament, and a vascular assessment that includes checking pulses in 
the legs and feet (ADA, 2019). The ADA (2019) adds that if a patient presents with decreased or 
absent pulses and/or symptoms of claudication, they should be referred for an ankle-brachial 
index to assess vascular status. If a diagnosis of PAD is established, a referral to a vascular 
specialist is warranted to evaluate the status and establish revascularization as needed (ADA, 
2019). 
Methods 
Project Plan  
The project leader developed a quality improvement project plan designed around the 
2019 ADA screening recommendations related to neuropathy and foot care. Specifically, the 
intervention included a plan to implement CFEs among adult patients with T2DM at the 
recommended intervals. These are the steps the project leader laid out in the planning phase of 
this project:   
1. Review EHR for CFE documentation capabilities. 
a. Incorporate a CFE documentation form into existing EHR, or 
b. Develop a new form for EHR, or 
c. Develop or identify a hard copy of the CFE form and create a mechanism to 
incorporate it into EHR. 
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2. Review EHR for the capacity to create employee/provider notification of the need for 
CFE based on ADA (2019) recommended intervals. 
a. If the capacity for notification exists withing EHR, activate this capacity. 
b. If capacity does not exist, develop a mechanism such as a pop-up notification 
that informs the provider and staff about T2DM diagnosis and the need for 
CFE screening.  
3. Identify and obtain supplies needed to complete CFE (e.g., 10g monofilament). 
4. Once the decision on CFE form and foot exam procedures is made, construct any 
necessary change in employee workflow and responsibilities. 
5. Educate primary care provider and office staff on procedure changes, role changes, 
and go-live date of February 11, 2020.  
6. Indicate to staff location of CFE documentation form (electronic or hard copy) to 
ensure accessibility when the project leader is unavailable.  
7. Educate staff regarding set up of patient exam rooms with the necessary supplies and 
tools to perform the exams (e.g., 10g monofilament). 
8. Provide a folder for staff and explain that they are to place completed CFE templates 
after they have been scanned into the patient EHR so that the project leader can assess 
completeness and weekly results. 
9. Ensure the availability of a shred box that met criteria outlined by the Health 
Insurance Portability and Accountability Act (HIPAA) of 1996 to shred the collected 
CFE templates every week. 
  
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  26 
Project Implementation 
The project leader, along with the provider and staff, began implementing CFEs for 
patients in February 2020. The first step towards initiation started in January 2020 when the 
project leader focused on education of the primary care provider and the office staff regarding 
the benefits of performing CFEs in primary care. Because the EHR did not have a CFE 
documentation form that could be accessed without reviewing each patient's entire record, the 
project leader explored with the provider the costs and benefits of making changes to the current 
EHR versus creating or identifying a hard copy CFE documentation template. When discussing 
the fee to build a new electronic CFE and notification system into the existing EHR, the software 
management company indicated that initial costs would start at $1000, and the provider was 
reluctant to move forward with this expense until the initial quality improvement project 
demonstrated the feasibility of this project. Therefore, it was decided with the provider's input to 
begin the project with a hard copy CFE documentation template adapted from the National 
Diabetes Education Program's (NDEP, n.d.) screening form. See Appendix A for the complete 
template. The CFE documentation template consisted of four sections: medical history, current 
history, foot exam, sensory foot exam, and risk categorization (NDEP, n.d.).  
After this was completed, the project leader identified capacities of the current EHR 
system and identified a method to link a care reminder pop-up notification to the EHR of patients 
with the diagnosis of T2DM. This notification was sent to all the staff in the clinic and appeared 
on their dashboard each morning. The notification informed the staff of which patients had an 
active T2DM diagnosis and would need a CFE. It should be noted that all previously 
documented CFEs were completed in 2019, so all T2DM patients were due for a CFE when they 
came for their next CDM appointment. Every morning after seeing the care reminder 
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notifications on their dashboard, the front desk MA was responsible for placing the CFE 
template (see appendix) on the patient information clipboard that was given to the provider 
before the provider examined each patient. The MA would be able to identify patients needing a 
CFE because the care reminder pop-up notification generated by the project leader is the only 
one of its kind. 
 A second MA, which is usually responsible for taking vital signs and updating 
information for the appointment would set up the exam room with the monofilament and patient 
information clipboard. That same MA was responsible for asking or assisting patients in 
removing their shoes and socks to prepare them for the assessment. After the provider completed 
a CFE, the form was scanned into the patient's chart by the MA who set up the room. The MA 
edited the date for the next CFE for the following year on the pop-up care reminder, and this date 
now actively appeared on the patient's record every time someone accessed it. To establish a new 
annual schedule and consider the time that a CFE might extend an appointment, CFEs were only 
performed on patients who were coming into the office for CDM visits, not on patients who 
came in for an acute illness appointment. The pop-up care reminder for the CFE would remain in 
place and could only be removed by the creator or the provider once the CFE was completed.  
This process worked for the first week of implementation in February 2020, however, it 
had to be revised after week 2. During week 2, this quality improvement project disrupted the 
flow of the front desk resulting in a significant decrease in CFE performance. The project leader 
met with the office staff and the provider to ask for input, and at that time, it was decided that the 
process would be modified. The original first step that required the front desk MA to place the 
form in the patient clipboard was modified and that task was delegated to the MA who obtained 
vital signs and documented visit information. This resulted in a smoother flow of events and did 
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not disrupt the flow of the front desk MA, who was tasked with answering phones, setting up 
appointments, and checking the patients in and out.  
Due to the COVID-19 pandemic, at week 7, the project leader supervised the project 
remotely. Every week from week 7 on the project leader would discuss results with the provider 
via telephone and video conferencing. Records were reviewed and evaluated remotely by the 
project leader through the use of a clinic laptop. To ensure the continuance of the project, the 
leader discussed opportunities for improvement and addressed any concerns or challenges 
incurred during the implementation process.  
Decision for intervention 
The decision to use a hard copy CFE template for documentation was made with the 
provider because the number, date, and frequency of CFEs performed were difficult if not 
impossible to track unless a person reviewed each patient's assessment record to see if a CFE 
was part of a physical exam. This obstacle became evident after the project leader explored the 
current EHR and found that there was no way to track individual CFE records as one could track 
mammograms or certain blood work such as HgA1c.  As stated previously, the addition of this 
feature to the EHR could only be implemented at a minimum cost of $1000 to the provider, and 
the consideration to add this feature was dependent on the results of this quality improvement 
project. At the time of the assessment, the only way to accurately know which patients received a 
CFE was by searching the current procedural terminology (CPT) code in the system. Moreover,  
not every patient would have the appropriate CPT code in their medical record unless they had 
been previously diagnosed with loss of protective sensation (LOPS) (Centers for Medicare & 
Medicaid Services, 2005). Therefore, it was decided that the project leader would manually set 
up a pop-up care reminder notification system for CFEs. 
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Barriers 
 Barriers to this project were not related to staff or provider unwillingness or push back, 
but rather to daily activities and occurrences that were unavoidable. Time was a barrier that 
could not be controlled because the flow of the clinic cannot be predicted and there is only one 
provider to see all the patients and perform the CFEs. Performing CFEs could add up to an 
additional 10 min to a visit that may have been scheduled initially as a 15 min visit. This could 
impact overall operations as well as patient wait time and satisfaction. Although these 
additional 10 min could be perceived as a positive factor for a patient whose visit was 10 min 
longer, this would not be the case for a patient who did not have that additional time with the 
provider.  
Another barrier to this QI project was the number of available staff. Although there was 
sufficient staff at the beginning of this project, there were only two MAs that actively 
participated in project implementation. The absence of one of these staff members could affect 
the actual performance of CFEs. When the clinic is short an MA, the office manager is required 
to perform the duties of the absent staff member in addition to their own administrative tasks; 
this leaves no room for MAs to assist with the performance of CFEs.  
The fact that the project leader was forced to work remotely served as a barrier as well. 
The presence of the project leader throughout the 11-week implementation period could have 
served as a facilitator by assisting with performance of CFEs, assistance with patients using 
telehealth technology, and by helping staff when time became a barrier.  
COVID-19  
One barrier that deserves special mention is the COVID-19 global pandemic, which 
resulted in a city-wide stay at home order during the project implementation period (City of San 
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Antonio, 2020). The implementation of this quality improvement project continued seamlessly 
until week 7 (March 25, 2020) when the project leader changed from in-person project 
supervisor to remote supervisor due to the project leader's possible risk of coronavirus exposure. 
The provider then assumed in-person responsibility for oversight and completion of CFEs and 
discussed results with the project leader weekly via telephone and video conferencing. During 
week 8, due to fear of community exposure to the coronavirus, many patients canceled their 
CDM appointments, and there was a significant decrease in the number of patients who received 
services. During that same week, the clinic was also closed for 2 days.  
By week 9 of the project (2nd week of April), a stay at home/ work safe declaration that 
was initiated by the mayor and county judge on March 23, 2020, further changed the dynamics 
of this project (City of San Antonio, 2020). This order, which was in place from March 24, 2020, 
through June 4, 2020, limited the reasons that a person could leave their home but allowed visits 
to health care providers. These events led to the provider's decision to offer services via 
telehealth during weeks 9 and 10.   
At that time, the project leader and provider decided to change the outcome criteria for 
weeks 9 and 10 for patients seen via a telehealth appointment. The outcome criteria for week 9 
and week 10 excluded the sensory evaluation and pulse palpation portion of the exam. It was 
noted that the risk categorization determination might not reflect the full patient risk.  
Week 11 was considered a transition week. After seeing that many patients had 
difficulties with the telehealth technology, the provider decided that both face-to-face and 
telehealth appointments would be offered.  
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Facilitators 
Facilitators for this project included support from the staff and the provider, including a 
willingness of all staff and the provider to communicate between themselves to incorporate a 
new process. The provider and the office staff made themselves available to the project leader 
since the project was proposed, and there was no resistance to change. 
Ethical Considerations 
The project leader submitted the project plan to the university institutional review board 
(IRB) with a letter of support from the provider (see Appendix B), and the project was deemed 
non-research by the IRB (see Appendix C). Because this quality improvement project was not a 
research study, no patient consent was needed; the only ethical consideration was patient 
privacy. Although identifying hardcopy documentation was created and scanned into the 
patients' EHR, patient information was disposed of appropriately. As instructed by the U.S. 
Department of Health & Human Services (n.d.), documents with protected health information  
were disposed of by a certified shredding company that renders those records as unreadable and 
unable to be reconstructed.  
Evaluation Plan 
The project leader created a formative and summative evaluation plan. The formative 
evaluation plan consisted of a review of the clinic processes once the project was implemented, a 
follow up on the accuracy of CFE documentation, and the gathering of key data weekly. The 
projected data to be gathered weekly included: the total number of patients with a diagnosis of 
T2DM seen for a CDM appointment, the number of patients who had a CFE performed, the 
number of documented CFEs with all aspects of the exam documented, and what, if any 
elements of documentation were lacking. The project leader planned to use data on the 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS 32 
percentage of completed exams each week to address process, material, personnel, or any 
unanticipated barriers that prevented at least a 50% completion and full documentation rate. The 
summative evaluation plan consisted of a compilation of the weekly evaluations summed for a 
total number and percentage of CFEs completed during the 11-week timeframe among those 
patients with T2DM seeking care during a CDM appointment. 
The criteria for CFE completion included the full performance documentation of a CFE, 
including the medical history, current history, foot exam, sensory foot exam, and risk 
categorization as classified on the documentation template. The completion criteria changed for 
weeks 9 and 10 (during the pandemic), where a completed CFE excluded assessment of pedal 
pulses and the sensory foot exam because visits were conducted via telehealth. Week 11 was a 
transition week where visits transitioned from telehealth to in-person visits; therefore, all aspects 
of CFE were expected to be performed and documented. The actual data gathered weekly from 
week 1-8 included the total number of patients with a diagnosis of T2DM seen for a CDM 
appointment, the number of those patients who had a CFE performed, and the number of CFE 
with all aspects of the exam documented. During weeks 9 and 10, the same data was gathered 
except the criteria for a complete documented CFE excluded the pedal pulse assessment and 
sensory foot exam. Table 4 provides a full result of the weekly findings and the final totals.   
Records were reviewed weekly by the project leader. Prior to changes in the practice 
process due to the impact of COVID-19, the project leader was able to gather data directly from 
the EHR at the clinic. The CFE templates that were collected weekly to assess performance were 
discarded in a shred box according to HIPAA laws. When the project leader began evaluating the 
project remotely, the provider allowed the leader to use a laptop from the clinic at home. This 
password-protected laptop gave the leader access to only weekly visit-related information and 
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had the clinic's EHR and network security software installed. This allowed the project leader to 
access data while maintaining HIPAA compliance.  
Results 
For the 1st week of implementation the project leader determined that there was a 60.8% 
CFE completion and documentation rate, which exceeded expectations, especially for the 1st 
week that the clinic staff had added tasks to their daily workflow. The leader noted that in the 2nd 
week there was a serious decline in CFEs with only a 20% completion rate. During week 2 
adjustments were made to the process and this reflected positively on week 3 with a completion 
and documentation rate of 53.8% CFEs, which represented a 33.8% increase over the previous 
decline. The adjustments required the change of roles between MAs. Originally, the front desk 
MA was responsible for placing the CFE template on the patient information clipboard given to 
the provider before the provider examined each patient. Because this process severely affected 
the workflow of the front desk, this task was assigned to a second MA who was already 
responsible for taking vital signs and setting up the exam room with the monofilament and 
patient information clipboard. This considerably improved the workflow and decreased the 
workload for the front desk MA  
During the formative evaluation period, the project leader discovered another decline in 
completed and documented CFEs which occurred during week 6 and week 7. The leader 
discussed these results with the provider and with the office staff. The decline in performed 
CFEs was due to the absence of the office manager who was out sick for the duration of those 2 
weeks. During the office manager’s absence, there was an increased workload on all of the staff 
including the provider. Therefore, project implementation was not priority as the staff and clinic 
flow were already being affected. 
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During week 8 the lowest number of patients were seen as the provider had a family 
emergency and had to close the clinic for several days; however, there was still 100% completion 
and documentation. During weeks 9 and 10, the clinic transitioned to a telehealth schedule due to 
the pandemic and the outcome criteria for CFE performance was modified as noted above. 
Results for these 2 weeks fluctuated as patients and staff adapted to the new platform for 
conducting patient visits.  
Week 11 was a transition week from telehealth to in-person visits and no patients needing 
a CFE were seen that week. At the end of the 11 weeks, there were a total of 111 patients seen 
for a CDM appointment with a diagnosis of T2DM, and 58 of those patients had a completed 
CFE with documentation in their EMR, yielding a total of 52% CFE completion. Refer to table 4 
for the weekly and final outcome. 
Finally, the project leader estimated that the performance of CFEs would add 
approximately 10 min to a patient appointment. While this was not measured specifically, the 
provider reported that CFE performance added anywhere from 10 to 20 min to a CDM 
appointment (telehealth or face-to-face). The time increase was dependent on staff preparedness, 







seen for CDM 
appointment 
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patients who had 
a full CFE 
performed  
All aspects of 
CFE 
documented 
from weeks 1-8 
Foot inspections 
documented 
weeks 9-10  








Week 1 23 14 14 60.8% 
Week 2 15 3 3 20% 
Week 3 13 7 7 53.8% 
Week 4 12 7 7 58.3% 
Week 5 18 14 14 77.7% 
Week 6 8 3 3 37.5% 
Week 7 9 3 3 33% 
Week 8 2 2 2 100% 
Week 9 6 2 33.3% 
Week 10 5 3 60% 
Week 11 0 0 ------ 
Totals 111 53 53 5 0 52% 
Note. On weeks 9 and 10, patients were only seen via telemedicine, and the criteria for CFE completion and documentation were 
modified due to the COVID-19 pandemic. The exams began with Week 1 on Tuesday, 02/11/2020, and culminated with Week 11, 
which began on 04/20/2020. Percentage of completed CFEs =  total documentation for CFEs for weeks 1-8 (53) + documentation of 
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Discussion 
Pocuis et al., (2017) performed a retrospective record review to assess provider 
performance of diabetic foot examinations per ADA guidelines. Pocuis et al., (2017) found that 
16% of the sample (n = 88) had a completed documented annual foot exams according to ADA 
guidelines. While the Pocuis et al. finding is higher than what the project leader identified prior 
to initiation of this project (0.3%), Pocuis et al. results indicate that the performance and 
documentation of annual foot exams needs improvement. Pocuis et al. explain that after 
inspecting patient records, they discovered that there was not a systematic way of documenting 
these exams. The documentation found was vague and did not follow a specific template or 
form. The only documentation that was considered as “complete” in the Pocuis et al. study was 
documented with the use of a checklist. These findings support the recommendation not only for 
the use of a template to document these exams but to integrate the CFE into the EHR to increase 
compliance with ADA guidelines. The findings from Pocuis et al. highlight the importance of 
using a documentation template like the one used in this project to accurately document an 
assessment and track its performance.  
Wu et al., (2018), conducted a retrospective cohort study and used multiple logistic 
regression to test for association between the use of a clinical reminder and recommended 
services by the ADA including HbA1C, retinal exam, and foot exam . The authors concluded 
that although there was an increase in foot exam performance with the use of a clinical reminder 
(from 5.7% to 8.6%, p = 0.06) it was not statistically significant. Additionally, Wu et al. 
suggested that practices with solo providers normally operate at a lower profit margin making 
cost a barrier for the adoption of clinical reminders. Both of these factors have been considered 
in this quality improvement project. Profit margin must be considered in QI projects such as the 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  
 
37 
one being presented here, and there is no evidence that the pop-up care reminder system for 
CFEs is the driving force behind the increased completion rate.  
Limitations 
One limitation of this quality improvement project was that use of a hard copy CFE 
template required completion by hand and scanning into the patient record to track CFE 
performance. This workaround, due to limited EHR capabilities, may decrease the likelihood of 
project sustainability and may place an extra work burden on staff and the provider. However, it 
is this type of project that may encourage smaller clinics to invest in a more robust EHR that can 
sustain greater changes.  
Another limitation relates to the COVID-19 global pandemic. Although the project 
continued during the COVID-19 pandemic and despite the stay home/ work safe orders 
established by city and county officials, the outcome had to be modified due to the change in 
visits from in person to telehealth. It is possible that some risk factors were missed when the 
sensory foot exam portion of the CFE had to be omitted in telehealth visits.  
Finally, this quality improvement project may have been impacted because the clinic's 
EHR did not have a CFE reminder function. This could tremendously affect the sustainability of 
this project because an accidental deletion of the pop-up care reminder that the leader created  
could ultimately alter future performance of this screening.  
Strengths 
A major strength of this project was the implementation of an evidence-based standard 
into practice. The project leader was able to take the ADA guidelines regarding foot screening 
for patients with T2DM and after a thorough needs assessment and planning process, implement 
an 11- week project where CFEs were completed and fully documented at least 50% of the time 
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instead of sporadically. This project demonstrates that an evidence-based recommendation such 
as the one pertaining to CFEs can be incorporated into a small primary care practice setting and 
may increase the number of foot complications that are identified early, thus decreasing the 
frequency of LEAs.  
Additionally, the selection of patients with T2DM with appointments for chronic disease 
management was performed in a more organized fashion. This process ensured the performance 
of CFEs during the implementation phase of this project.  
Recommendations  
It would be of great benefit to repeat this quality improvement project at another time 
after the resolution of this pandemic and possibly for a longer time frame. Implementing this 
project at another time could improve the quality of results and serve as beneficial to other 
primary care practices with the same area for improvement. Also, implementing this project over 
a longer period of time could improve results where a large decline was witnessed due to these 
patients being seen every 3 months for follow-up. Unfortunately, because the COVID-19 
pandemic has not entirely resolved at this time and continues to evolve, other recommendations 
are necessitated for an increase in completion rates.  
Expanding the role of the chronic care management RN may influence the sustainability 
of this project in the long run. When the position for RN is filled, it would be of great value for 
the RN to assist with tracking and performing CFEs at home with the supervision of the provider 
since they will already be contacting these patients for follow-up. 
Another recommendation would be for the provider to invest in a more robust EHR that 
allows the creation of documentation, tracking, and reminder features.  The capability of the 
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EHR system to add the CFE to the patients' records may improve completion rates and 
ultimately, patient outcomes.  
Implications 
Because T2DM is a chronic illness that requires frequent follow-up and chronic 
management, it would be prudent to suggest that the performance and documentation of CFEs 
become a healthcare effectiveness data and information set (HEDIS) measure. HEDIS is a 
performance improvement tool that measures performance in healthcare areas where 
improvements can be made (National Committee for Quality Assurance, n.d.). The addition of 
CFE as a HEDIS measure can improve the effectiveness of prevention and screening tools such 
as the CFE and, in the long run, improve patient outcomes in the primary care setting.  
The DNP-prepared nurse practitioner focuses on a continuum of care and understands 
how to measure outcomes of new models of care (Beeber et al., 2019). The DNP also has the 
skills and the groundwork for bridging the gap between new models of care and superior patient 
outcomes. This factor is vital because foot ulcers are one of the most common and preventable 
complications of T2DM, and 20% of them result in amputations (Armstrong et al., 2017).  
Conclusion 
Because foot ulcers are one of the most common and preventable complications of 
T2DM and 20% of them result in amputations, primary care providers must be up to date with 
the most current standards of care (Armstrong et al., 2017) and be willing to put evidence-based 
guidelines into practice.  Being up to date with the most current standards of care and having the 
resources in one's practice set to track outcomes can make a significant difference in the quality 
of a patient's life. Foot ulcers and amputation are major causes of morbidity and mortality in 
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patients with DM. Therefore, the completion of CFEs in 52% of patients in the practice, may be 






















IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS 41 
References 
American Diabetes Association. (2017a). The burden of diabetes in Texas. 
http://main.diabetes.org/dorg/PDFs/Advocacy/burden-of-diabetes/texas.pdf 
American Diabetes Association. (2017b). The cost of diabetes. 
https://www.diabetes.org/resources/statistics/cost-diabetes?language_content_entity=en 
American Diabetes Association. (2018). Statistics about diabetes. 
https://www.diabetes.org/resources/statistics/statistics-about-diabetes 
American Diabetes Association. (2019). Standards of medical care in diabetes-2019. Diabetes 
Care, 42. http://dx.doi.org/https://doi.org/10.2337/dc19-Sint01 
Armstrong, D. G., Boulton, A. J., & Bus, S. A. (2017). Diabetic foot ulcers and their recurrence. 
New England Journal of Medicine, 376(24), 2367-2375. 
http://dx.doi.org/10.1056/NEJMra1615439 
Beeber, A. S., Palmer, C., Waldrop, J., Lynn, M. R., Jones, C. B. (2019). The role of Doctor of 
Nursing Practice-prepared nurses in practice settings. Nursing Outlook, 67(4), 354-363. 
https://doi.org/10.1016/j.outlook.2019.02.006 
Callaghan, B. C., Price, R. S., & Feldman, E. L. (2020). Distal symmetric polyneuropathy in 
2020. JAMA Neurology, 324(1), 90–91. https://doi.org/10.1001/jama.2020.0700 
Centers for Disease Control and Prevention. (2016a.). Hospitalizations for lower extremity 
amputations in adults with diabetes, United States. 
https://nccd.cdc.gov/Toolkit/DiabetesBurden/Hospitalization/Lea 
Centers for Disease Control and Prevention. (2016b). Hospitalizations for lower extremity 
amputations in adults with diabetes, Texas, 2014. 
https://nccd.cdc.gov/Toolkit/DiabetesBurden/Hospitalization/Lea 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  
 
42 
Centers for Disease Control and Prevention. (2017). Diabetes 2017 report card. 
https://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2017-508.pdf 
Centers for Disease Control and Prevention. (2019). Diabetes. 
https://www.cdc.gov/diabetes/basics/diabetes.html 
Centers for Disease Control and Prevention. (2020). Initial public health response and interim 
clinical guidance for the 2019 novel coronavirus outbreak- United States, December 31, 
2019-February 4, 2020. 
https://www.cdc.gov/mmwr/volumes/69/wr/mm6905e1.htm?s_cid=mm6905e1_w 
Centers for Medicare & Medicaid Services (2005). Billing of the diagnosis and treatment of 
peripheral neuropathy with loss of protective sensation in people with diabetes. 
https://www.cms.gov/Regulations-and-
Guidance/Guidance/Transmittals/downloads/r498cp.pdf 








Hicks, C. W., & Selvin, E. (2019). Epidemiology of peripheral neuropathy and lower extremity 
disease in diabetes. Current Diabetes Report, 19(10). http://dx.doi.org/10.1007/s11892-
019-1212-8 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  
 
43 
Juster-Switlyk, K., & Smith, A. G. (2016). Updates in diabetic peripheral neuropathy. F1000 
Research, 5(738), 3-7. http://dx.doi.org/10.12688/f1000research.7898.1 
Khalil, H. (2017). Diabetes microvascular complications—A clinical update. Diabetes & 
Metabolic Syndrome: Clinical Research & Reviews, 11(1), s133–s139. 
https://doi.org/10.1016/j.dsx.2016.12.022 
Lung, C., Wu, F., Liao, F., Pu, F., Fan, Y., & Jan, Y. (2020). Emerging technologies for the 
prevention and management of diabetic foot ulcers. Journal of Tissue Viability, 29(2),  
61-68. https://doi.org/10.1016/j.jtv.2020.03.003  
Ming, A., Walter, I., Alhajjar, A., Leuckert, M., & Mertens, P. R. (2019). Study protocol for a 
randomized controlled trial to test for preventive effects of diabetic foot ulceration by 
telemedicine that includes sensor-equipped insoles combined with photo documentation. 
Trials, 20(521), 2-10. https://doi.org/10.1186/s13063-019-3623-x 
National Committee for Quality Assurance. (n.d.). HEDIS measures and technical resources. 
https://www.ncqa.org/hedis/measures/ 
National Diabetes Education Program. (n.d.). Comprehensive diabetes foot examination form. 
Centers for Disease Control and Prevention. 
https://www.cdc.gov/diabetes/ndep/index.html 
Pocuis, J., Li, S. M., Janci, M. M., & Thompson, H. J. (2017). Exploring diabetic foot exam 
performance in a specialty clinic. Clinical Nursing Research, 26(1), 82-92. 
http://dx.doi.org/10.1177/1054773815596699 
Pop-Busui, R., Boulton, A. J., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. 
M., & Ziegler, D. (2017). Diabetic neuropathy: A position statement by the American 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  
 
44 
Diabetes Association. Diabetes Care, 40(1), 136-154. 
http://dx.doi.org/https://doi.org/10.2337/dc16-2042 
Raghav, A., Khan, Z. A., Labala, R. K., Ahmad, J., Noor, S., & Mishra, B. K. (2018). Financial 
burden of diabetic foot ulcers to the world: A progressive topic to discuss always. 
Therapeutic Advances in Endocrinology and Metabolism, 9(1), 29-31. 
http://dx.doi.org/https://doi.org/10.1177/2042018817744513 
San Antonio Metropolitan Health District. (2019). Diabetes in Bexar County- 2017/2018 report. 
https://www.sanantonio.gov/Portals/0/Files/health/News/Reports/Diabetes/DiabetesRepor
t2017-2018.pdf 
Sunil, T., Limon, A., & Ochoa, L. (2019). Lower extremity amputation among diabetic patients 
in San Antonio, Texas. Hispanic Health Care International, 17(2), 73-78. 
http://dx.doi.org/10.1177/1540415319828267 
Tappen, R. M., Wolf, D. G., Rahemi, Z., Engstrom, G., Rojido, C., Shutes, J. M., & Ouslander, J. 
G. (2017). Barriers and facilitators to implementing a change initiative in long-term care 
utilizing the INTERACT quality improvement program. The Health Care Manager, 
36(3), 219-230. http://dx.doi.org/10.1097/HCM.0000000000000168 
The Dartmouth Institute Microsystem Academy. (2005). Clinical microsystems: Assessing, 
diagnosing and treating your outpatient primary care practice. 
https://clinicalmicrosystem.org/knowledge-center/workbooks/ 
U.S. Department of Health & Human Services. (n.d.). What do the HIPAA privacy and security 
rules require of covered entities when they dispose of protected health information?  
https://www.hhs.gov/hipaa/for-professionals/faq/575/what-does-hipaa-require-of-
covered-entities-when-they-dispose-information/index.html 
IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS  
 
45 
World Health Organization. (2020). About diabetes. 
https://www.who.int/diabetes/action_online/basics/en/index3.html      
Wu, S. S., Chan, K. S., Bae, J., & Ford, E. W. (2018, September 12). Electronic clinical reminder 




IMPLEMENTATION OF COMPREHENSIVE FOOT EXAMS 46 
Appendix A
 
CFE Documentation Template 
Comprehensive Diabetes Foot Examination For 
Adapted from the National Diabetes Education Program's Foot Screening Form 
Name: Date: Age: 
Age at Onset: Diabetes Type □ 1 □ 2 Current Treatment: □ Diet 
m 
□ Oral □ Insulin
I. Medical History





□ Peripheral Vascular Disease
II. Current History
1. Any change in the foot or feet since the last evalua- 
tion?
□ Yes □ No
2. Current ulcer or history of a foot ulcer?
□ Yes □ No
3. Is there pain in the calf muscles when walking that is
relieved by rest?
□ Yes □ No
III. Foot Exam
1. Are the nails thick, too long, ingrown or infected with fungal disease?
□ Yes □ No
2. Note foot deformities.
□ Toe deformities □ Bunions □ Charcot foot □ Foot drop
□ Prominent metatarsal heads
□ Amputation (Specify date, side and level.)
3. Pedal Pulses
(Fill in the blanks with a "P" or an "A" to indicate present or
absent.) Posterior tibial: Dorsalis pedis: 
Left Left 
Right Right 
4. Skin Condition (Measure, draw in and label the patient's skin condi- 
tion using the key and foot diagram to the right.)
C = Callus R = Redness W = Warmth 
F = Fissure S = Swelling U = Ulcer 
M = Maceration PU = Pre-ulcerative lesion D = Dryness 
IV. Sensory Foot Exam
Label sensory level with a "+" in the five circled areas of
the foot if the patient can feel the 5.07 Semmes-
Weinstein (10-gram) nylon filament and "-" if the patient
cannot feel the filament.
NOTES NOTES 
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V. Risk Categorization (Check appropriate item.) 
Low-Risk Patient 
All of the following: 
□ Intact protective sensation □ No severe deformity 
□ No prior foot ulcer □ Pedal pulses present 
□ No severe deformity □ No amputation 
High-Risk Patient 
One or more of the following: 
□ Loss of protective sensation 
□ Absent pedal pulses 
□ Severe foot deformity 
□ History of foot ulcer 
VI. Footwear Assessment 
1. Does the patient wear appropriate shoes? 
□ Yes □ No 
2. Does the patient need inserts/orthotics? 
□ Yes □ No 
VII. Education 
1. Has the patient had prior foot care education? 
□ Yes □ No 
2. Can the patient demonstrate appropriate self-care? 
□ Yes □ No 
VII. Management Plan (Check all that apply.) 
□ Provide patient education for preventive foot care. □ Refer to an APMA member podiatrist or an appropriate physician. 
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Appendix B
 Letter of Support 
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Appendix C
 
Human Subjects Research Determination 
